Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432

This publication has 28 references indexed in Scilit:

• Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination
  International Journal of Cancer, 2008
• Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
  Clinical Cancer Research, 2008
• HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival
  Diseases of the Esophagus, 2006
• Heterogeneous expression of GAGE, NY‐ESO‐1, MAGE‐A and SSX proteins in esophageal cancer: Implications for immunotherapy
  International Journal of Cancer, 2005
• Expression Profile of Cancer-Testis Genes in 121 Human Colorectal Cancer Tissue and Adjacent Normal Tissue
  Clinical Cancer Research, 2005
• Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma
  Journal of Cancer Research and Clinical Oncology, 2004
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
  Seminars in Radiation Oncology, 2003
• Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
  International Journal of Cancer, 2001
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI: Journal of the National Cancer Institute, 2000
• Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis
  European Journal of Surgical Oncology, 1997